Treatments for acute lymphoblastic leukemia: A comparison between Tisagenlecleucel and Clofarabine

Background: Acute lymphoblastic leukemia (ALL) is a heterogeneous hematological malignancy predominantly affecting individuals under 20 years of age. Traditional chemotherapy, such as clofarabine, has shown efficacy; however, novel immunotherapeutic strategies like tisagenlecleucel (Kymriah®) have s...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Carmona, Rocío Guadalupe, Montivero, Malena, Quattrocchi, Georgina, Zarelli, Valeria, Giai, Constanza, Quintero, Cristián Andrés
Formato: Artículo Científico
Lenguaje:Inglés
Publicado: 2025
Materias:
tisagenlecleucel
clofarabina
leucemia linfoblástica aguda
Acceso en línea:https://repositorio.umaza.edu.ar/handle/00261/3607
Aporte de:
UMAZA Digital (Universidad MAZA - Mendoza) de Universidad Juan Agustín MAZA

Ejemplares similares

Ejemplares similares